Related Experiment Video
Updated: Oct 23, 2025
07:22
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
3.8K
MST and TRIC Technology to Reliably Study PROTAC Binary and Ternary Binding in Drug Development
Tanja Bartoschik1, Andreas Zoephel2, Klaus Rumpel2
1NanoTemper Technologies GmbH, Munich, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|August 25, 2021
Summary
Proteolysis-targeting chimeras (PROTACs) offer a novel therapeutic strategy by degrading target proteins. MicroScale Thermophoresis (MST) and Temperature-Related Intensity Change (TRIC) assays enable efficient characterization of PROTACs for drug discovery.
Area of Science:
- Biochemistry
- Chemical Biology
- Drug Discovery
Background:
- Proteolysis-targeting chimeras (PROTACs) represent a novel therapeutic modality distinct from traditional small molecules.
- PROTACs leverage the body's ubiquitin-proteasome system to induce targeted protein degradation, offering potential advantages like enhanced sensitivity and reduced off-target effects.
- The unique mechanism of action (MOA) of PROTACs requires specialized drug discovery techniques for characterization.
Purpose of the Study:
- To present MicroScale Thermophoresis (MST) and Temperature-Related Intensity Change (TRIC) as powerful techniques for PROTAC characterization.
- To demonstrate the application of MST and TRIC in analyzing both binary and ternary binding interactions critical for PROTAC efficacy.
- To showcase the utility of these methods in determining the cooperativity of ternary complex formation and facilitating PROTAC discovery.
Main Methods:
- MicroScale Thermophoresis (MST) for analyzing biomolecular interactions.
- Temperature-Related Intensity Change (TRIC) for characterizing binding events.
- Assay development and experimental validation using the BET PROTAC MZ1.
Main Results:
- MST and TRIC assays were successfully developed and applied to characterize the binary and ternary binding of PROTACs.
- These methods efficiently determined the cooperativity of ternary complex formation between PROTACs, target proteins, and ubiquitin ligases.
- The BET PROTAC MZ1 was used as a model to demonstrate the speed and sensitivity of MST and TRIC in PROTAC research.
Conclusions:
- MST and TRIC are fast, highly sensitive, and effective methods for characterizing PROTACs.
- These techniques are valuable tools for advancing PROTAC-based drug discovery by elucidating complex molecular interactions.
- The application of MST and TRIC can accelerate the development of novel therapeutics utilizing targeted protein degradation.
More Related Videos
Related Concept Videos
01:33Peptide Identification Using Tandem Mass Spectrometry
7.3K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
7.3K
01:28Structure-Activity Relationships and Drug Design
1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
02:18The Equilibrium Binding Constant and Binding Strength
14.3K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.3K